SENS: Ascending Triangle (81%)This figure is not confirmed yet. Must break the 4$ resistance with volume to confirm. If confirmed: Price target = 7.50$ Stay humble, have fun, make money!Longby LeLaf2213
Sens must break through the 4.00 area in order to move to 4.70.If Sens can break through and hold the 4 area it will make an attempt at 4.70.Longby eallgeiUpdated 2
$SENS Potential Breakout$SENS looks like it is breaking out of this symmetrical triangle. Volume is currently dying down so waiting on a pullback to enter. FDA approval is in the air and now wouldn't be a bad time to scale in! PT is previous high of $4.58 level.Longby DarthTrador118
SENS Macro Target - New Forecast!First Target is $4. If bullish cup and handle play out then this can shoot to the 1.618 fib at $7. Bullish!by ILuminosity6
$SENS What's Next?Noted in the trend band, $SENS has floated within its average for the last 3 months, with a small upward move from its initial 180 day CGM submission to the FDA. Although $SENS has report net loss, it is expected from a company within its product growth cycle. Additionally, new employees were hired to speed the R & D of its programming and engineering. New Employees were paid in equity shares, and lockup is until milestones are achieved, which has contributed to its expenses. So, whats next? The 180 CGM sensor is still in play as FDA has it on the table for review. Considering the extent of healthcare networks added to the market, another potential for $SENS is a merger or partnership from big pharma. Longby mrtnquint113
This looks good for a runCorrection looks to be over and we should see the next wave upLongby rbswingtrader5
Sens Harmonics: Let's Ride!Here we have a bullish bat pattern, on the daily. I would enter at the top of the entry envelope. Widening the PRZ, I added the extra 1.618 extension below the retracement entry envelope because there appears to be an extension pattern that suggests some drawdown passed the 0.886 retracement. I'd keep stop loss at 5% below 1.74. Good luck, trade safely, and let's make that money!Longby Antikythera_Mechanism1
SENS - good fundamentals - long swingrecommendation of friend. Technicals are good, he likes the fundamentalsLongby Megamago4
SENS Back Testing The 382 Fib Watching To Act As SupportThe thing about SENS is that it's been a company crushing it in 2021. When it was first discussed this year it was still trading below $1. Despite recent volatility, it's up significantly year-to-date. I think volume remains steady but definitely on the lower end of the range. But good data from the last presentation on its PROMISE study seems to have sparked more attention. "The data evaluating the safety and accuracy of the next generation Eversense system was presented by Satish Garg , MD, Professor of Medicine at the Barbara Davis Center of the University of Colorado, Denver , and the PROMISE study group Principal Investigator (PI). The Company presented previously released information demonstrating performance matching that of the current 90-day sensor available in the United States , with reduced calibration, down to one per day, with duration extended to 180 days. Accuracy measurements discussed in the oral presentation include a mean absolute relative difference (MARD) of 9.1% for the primary sensor and confirmed hypoglycemia alert detection rates at 60 mg/dL of 87% and at 70 mg/dL of 93%. For the subset of 43 modified sensors (referred to as the SBA sensor), the MARD was 8.5% and the confirmed hypo alert detection rates at 60 mg/dL and 70 mg/dL were 90% and 94%, respectively." Another area of potential support/resistance is just below the 382 fib line (in yellow), which has held so far this week. It was resistance a few weeks back. With SENS failing almost right at the 236 Fib line, technical traders are liking monitoring these levels closely. Latest on SENS: Best Penny Stocks to Buy Right Now? 7 Small-Caps For Your Morning Listby PennyStocks1012
Retracements gives a buy at dip opptyPer previous post, its going to retrace to $2.2 to $2.5 range and is a good dip buy oppty. Longby rbswingtrader115
$sens w3 setupclean 1-2-3-4-5 into the (1) now we get an a-b-c down into my golden zone for the (2), where i will become a buyer. wave 3 target - 12 wave 5 target - 30+ by notoriousbids226
SENS BUY/LONG NOW READY! 2.95 TO 6.75 BY SEPT 2021TICKER CODE: SENS Company Name: SENSEONICS HOLDINGS, INC. Industry: ELECTRONIC TECHNOLOGY. ELECTRONIC COMPONENTS Position Proposed: BUY/LONG Entry: BUY READY (2.85-2.95) 1st Partial Take Profit: 5.67 (JUNE 2022-AUG 2022) 2nd Partial Take Profit: 6.75 (OCT 2022-DEC 2022) Potential Full Take Proft: 9.93 (Mid YR 2023- Early 2024) Stop Loss: 1.65-1.70 Technical Analysis 1. Speaker Phone Formation would Indicate a Potential BUY to Take Profit Levels. 2. Inverse Head & Shoulders forming indicating a Potential BUY to Take Profit Levels. 3. Flagpole + Falling Wedge Formed and Done Retracement indicating a Potential BUY to Take Profit Levels. 4. Fibonacci levels indicate a Retracement at Golden Zone (0.786) to Levels 5.67, 6.75, and FInally 9.93 in the Following Years. Longby traderprosignalsUpdated 226
$SENS can rise in the next daysContextual immersion trading strategy idea. Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $2.91; stop-loss — $2.52. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!Longby KozakHlibUpdated 112
Looking for a entry point...Any advice would be great :) here to learn open to comments and knowledge AMEX:SENSLongby Mcmy88112
This makes SENSWon't enter now but wait for some pullback. This is a good stock to go long on. Longby rbswingtrader6611
I have a good sense about SENSWe can see a clear triangle, I am expecting a bullish breakout. lets see what is going to happen!!!Longby Alexander_papito4
SENS Symmetrical Triangle Pattern - 15min Breakout from triangle upward past that resistance. Possibly see $3.26 very soon.Longby jonnejohnson226
$SENS Cheapie w Huge Volume and Large move potential $SENS Broke out of not one but 2 high tight flags, might not pullback but if it does we would find this attractive around the 2.50 mark. It closed in the cypher window in the 1 hour tf, which can lead to pullback, I do not care for this pattern in low time frame but it is possible they try to shake week hands on this before they run it up. Worth setting price alert for at minimum. Thanks for looking guys and good luck this week. Some DD for you if you have any interest in the name = www.zacks.com app.koyfin.comLongby HiddenharmonicstradingUpdated 5517
SENS - Coming back to its senses! 🙌-Shares of Senseonics (NYSEMKT:SENS) are on the march in Friday’s pre-market action stock after the medtech firm reported positive test results for its glucose-monitoring system. SENS stock was up more than 30% at 8:30 a.m. Eastern. -SENS stock closed Thursday at $2.05 a share after surging over the past six month. The shares used to trade deep in penny stock territory, below 50 cents through most of 2020. -Senseonics is focused on developing and commercializing long-term implantable continuous glucose monitoring systems, or CGMs, for patients with diabetes. It is novel in that it can be implanted and then provide data for up to six months. -Big move comes after the firm said study results for both a primary and secondary glucose sensor — or an SBA sensor — showed promising preliminary results. The study sought to evaluate Senseonics’ Eversense CGM System in patients with diabetes, testing them over a 180-day period. The study is the basis of the pre-market application submissions to the U.S. Food and Drug Administration and to European regulators for a CE mark, the company said.Longby caldooninvestment1616102
SENS- Symmetrical Triangle Analysis (Breakout Soon)Symmetrical Triangle Pattern is seen in SENS Beware of a breakout either uptrend or downtrend soon $SENS #Senseonics Holdings, Incby krinxeUpdated 12126